Spots Global Cancer Trial Database for folfoxiri protocol
Every month we try and update this database with for folfoxiri protocol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Induction Chemotherapy for Locally Advanced Rectal Cancer | NCT04838496 | Rectal Cancer | FOLFOXIRI Proto... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | NCT04325425 | Neuroendocrine ... | FOLFOXIRI Proto... Cisplatin injec... | 18 Years - | Centre Hospitalier Universitaire Dijon | |
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | NCT03975049 | Rectal Cancer Chemotherapy Ef... | Chemoradiation FOLFOXIRI Proto... Folfox Protocol | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
Induction Chemotherapy for Locally Advanced Rectal Cancer | NCT04838496 | Rectal Cancer | FOLFOXIRI Proto... | 18 Years - | Catharina Ziekenhuis Eindhoven | |
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | NCT04325425 | Neuroendocrine ... | FOLFOXIRI Proto... Cisplatin injec... | 18 Years - | Centre Hospitalier Universitaire Dijon | |
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | NCT03975049 | Rectal Cancer Chemotherapy Ef... | Chemoradiation FOLFOXIRI Proto... Folfox Protocol | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | NCT04325425 | Neuroendocrine ... | FOLFOXIRI Proto... Cisplatin injec... | 18 Years - | Centre Hospitalier Universitaire Dijon |